PL1748954T3 - Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania - Google Patents

Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania

Info

Publication number
PL1748954T3
PL1748954T3 PL05727242T PL05727242T PL1748954T3 PL 1748954 T3 PL1748954 T3 PL 1748954T3 PL 05727242 T PL05727242 T PL 05727242T PL 05727242 T PL05727242 T PL 05727242T PL 1748954 T3 PL1748954 T3 PL 1748954T3
Authority
PL
Poland
Prior art keywords
phospholipases
making
methods
nucleic acids
acids encoding
Prior art date
Application number
PL05727242T
Other languages
English (en)
Inventor
Svetlana Gramatikova
Geoff Hazlewood
David Lam
Nelson R. Barton
Blake G. Sturgis
Dan E. Robertson
Jincai Li
Joel A. Kreps
Roderick Fielding
Robert C. Brown
Amit Vasavada
Xuqiu Tan
Adrian Badillo
Hoek Wilhelmus P. Van
Giselle Janssen
Charles Isaac
Mark J. Burk
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of PL1748954T3 publication Critical patent/PL1748954T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6418—Fatty acids by hydrolysis of fatty acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6458—Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6481—Phosphoglycerides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL05727242T 2004-03-08 2005-03-08 Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania PL1748954T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/796,907 US7226771B2 (en) 2002-04-19 2004-03-08 Phospholipases, nucleic acids encoding them and methods for making and using them

Publications (1)

Publication Number Publication Date
PL1748954T3 true PL1748954T3 (pl) 2017-02-28

Family

ID=34976224

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05727242T PL1748954T3 (pl) 2004-03-08 2005-03-08 Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania

Country Status (12)

Country Link
US (2) US7226771B2 (pl)
EP (2) EP3190182A1 (pl)
JP (2) JP2007531516A (pl)
CN (1) CN101426918B (pl)
AU (1) AU2005221136B2 (pl)
BR (1) BRPI0508559B1 (pl)
CA (1) CA2559060C (pl)
ES (1) ES2601431T3 (pl)
HU (1) HUE030573T2 (pl)
PL (1) PL1748954T3 (pl)
PT (1) PT1748954T (pl)
WO (1) WO2005086900A2 (pl)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69604491T3 (de) 1995-06-07 2008-09-25 Danisco A/S Methode zur verbesserung der eigenschaften von mehlteig, sowie zusammensetzung zur teigverbesserung und verbesserte nahrungsmittel
US6936289B2 (en) 1995-06-07 2005-08-30 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
GB0112226D0 (en) * 2001-05-18 2001-07-11 Danisco Method of improving dough and bread quality
US20050287250A1 (en) * 1995-06-07 2005-12-29 Danisco A/S Method
WO2000005396A1 (en) * 1998-07-21 2000-02-03 Danisco A/S Foodstuff
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
EP1387616B1 (en) 2001-05-18 2007-05-16 Danisco A/S Method of preparing a dough with an enzyme
US7943360B2 (en) 2002-04-19 2011-05-17 Verenium Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
US7226771B2 (en) * 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
US7955814B2 (en) * 2003-01-17 2011-06-07 Danisco A/S Method
US20050196766A1 (en) * 2003-12-24 2005-09-08 Soe Jorn B. Proteins
DE602004030000D1 (de) * 2003-01-17 2010-12-23 Danisco Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel
CA2889013C (en) 2003-03-07 2018-07-17 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
GB0716126D0 (en) * 2007-08-17 2007-09-26 Danisco Process
US7718408B2 (en) * 2003-12-24 2010-05-18 Danisco A/S Method
US7906307B2 (en) * 2003-12-24 2011-03-15 Danisco A/S Variant lipid acyltransferases and methods of making
GB0405637D0 (en) 2004-03-12 2004-04-21 Danisco Protein
US20080070291A1 (en) 2004-06-16 2008-03-20 David Lam Compositions and Methods for Enzymatic Decolorization of Chlorophyll
EP1776455B1 (en) * 2004-07-16 2015-03-18 DuPont Nutrition Biosciences ApS Lipolytic enzyme, uses thereof in the food industry
US8557551B2 (en) 2004-09-10 2013-10-15 Dsm Ip Assets B.V. Compositions and methods for making and modifying oils
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
EP1788080A1 (en) * 2005-11-22 2007-05-23 Süd-Chemie Ag Use of a thermostable phospholipase in the degumming of an oil or fat, and a method for obtaining a thermostable phopholipase
US20070148311A1 (en) * 2005-12-22 2007-06-28 Bunge Oils, Inc. Phytosterol esterification product and method of make same
US20080215251A1 (en) * 2006-08-31 2008-09-04 Pioneer Hi-Bred International, Inc. Computational method for choosing nucleotide sequences to specifically silence genes
ES2451266T3 (es) * 2006-09-21 2014-03-26 Dsm Ip Assets B.V. Fosfolipasas, ácidos nucleicos que las codifican, y métodos para obtenerlas y usarlas
CN101652474B (zh) * 2007-01-25 2012-06-27 丹尼斯科有限公司 由地衣芽孢杆菌转化细胞制备脂酰基转移酶
US8956853B2 (en) * 2007-01-30 2015-02-17 Bunge Oils, Inc. Enzymatic degumming utilizing a mixture of PLA and PLC phospholipases
US8460905B2 (en) * 2007-09-11 2013-06-11 Bunge Oils, Inc. Enzymatic degumming utilizing a mixture of PLA and PLC phospholipases with reduced reaction time
PL2118248T3 (pl) * 2007-01-30 2015-03-31 Bunge Oils Inc Enzymatyczne odśluzowywanie wykorzystujące mieszaninę fosfolipaz PLA i PLC
MX2010002825A (es) 2007-09-12 2010-08-31 Martek Biosciences Corp Aceites biologicos y produccion y usos de los mismos.
BRPI0821253A2 (pt) * 2007-12-21 2015-06-16 Danisco Método de degomagem, método de tratamento de uma fase de goma e uso de lipídio aciltransferase na degomagem com água de um óleo comestível
US8241876B2 (en) 2008-01-07 2012-08-14 Bunge Oils, Inc. Generation of triacylglycerols from gums
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (en) 2008-07-01 2019-06-12 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
US20110113315A1 (en) * 2008-12-31 2011-05-12 Microsoft Corporation Computer-assisted rich interactive narrative (rin) generation
US20110119587A1 (en) * 2008-12-31 2011-05-19 Microsoft Corporation Data model and player platform for rich interactive narratives
US9092437B2 (en) * 2008-12-31 2015-07-28 Microsoft Technology Licensing, Llc Experience streams for rich interactive narratives
ES2668909T3 (es) 2009-01-06 2018-05-23 Galenagen, Llc Composiciones que comprenden proteasa, amilasa y lipasa para su uso en el tratamiento de infecciones por Staphylococcus aureus
US9084784B2 (en) * 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
CA2754387C (en) * 2009-03-10 2018-11-13 Dsm Ip Assets B.V. Pregastric esterase and derivatives thereof
GB0904787D0 (en) * 2009-03-20 2009-05-06 Desmet Ballestra Engineering Sa Improved enzymatic oil recuperation process
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9315764B1 (en) * 2009-05-01 2016-04-19 Rrip, Llc Method of processing phospholipid based lipid materials
WO2010150213A1 (en) * 2009-06-25 2010-12-29 Danisco A/S Protein
CN105341355A (zh) * 2009-10-14 2016-02-24 希乐克公司 从乙醇生产中产生可食用残留物
UA111708C2 (uk) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. Спосіб рафінування олії
UA109884C2 (uk) * 2009-10-16 2015-10-26 Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
WO2011090730A1 (en) * 2009-12-28 2011-07-28 Martek Biosciences Corporation Recombinant thraustochytrids that grow on xylose, and compositions, methods of making, and uses thereof
WO2011082190A1 (en) 2009-12-28 2011-07-07 Martek Biosciences Corporation Recombinant thraustochytrids that grow on sucrose, and compositions, methods of making, and uses thereof
DE102010025764A1 (de) 2010-07-01 2012-01-05 Süd-Chemie AG Phospholipase-Träger-Komplex
WO2012054585A2 (en) * 2010-10-19 2012-04-26 The Curators Of University Of Missouri-St. Louis Method for increasing plant oil production
WO2012062817A1 (en) * 2010-11-12 2012-05-18 Novozymes A/S Polypeptides having phospholipase c activity and polynucleotides encoding same
GB201019639D0 (en) * 2010-11-19 2010-12-29 Loders Croklaan Bv Method
CN106310242B (zh) 2011-04-21 2020-02-28 柯尔马克有限责任公司 用于治疗神经精神障碍的化合物
TWI414362B (zh) 2011-05-18 2013-11-11 Ind Tech Res Inst 萃取裝置
US8586387B2 (en) * 2011-08-30 2013-11-19 Supernova Diagnostics, Inc. Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances
WO2013122599A1 (en) * 2012-02-17 2013-08-22 Sunho Biodiesel America Llc Enzymatic production of monoglycerides
CN104245908B (zh) 2012-02-17 2017-03-01 科莱恩产品（德国）有限公司 用于酶法油脱胶的方法
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US9657319B2 (en) 2012-06-14 2017-05-23 Bunge Global Innovation Llc Process for production of low saturate oils
CA2873378C (en) * 2012-07-04 2020-01-14 Cooperatie Avebe U.A. Lipase in short-chain esterification of fatty acids
DK2964775T3 (en) 2013-03-08 2019-04-15 Biogrammatics Inc Yeast promoters for protein expression
PL2964765T3 (pl) * 2013-03-08 2019-10-31 Keck Graduate Inst Of Applied Life Sciences Promotory drożdżowe z pichia pastoris
US10294463B2 (en) * 2013-07-03 2019-05-21 Keclon Sa Modified Bacillus cereus phospholipase C protein and method of processing vegetable oil
CN104630174B (zh) * 2013-11-07 2019-09-27 丰益(上海)生物技术研发中心有限公司 磷脂酶c突变体及其用途
CN104630175B (zh) * 2013-11-14 2019-10-25 丰益(上海)生物技术研发中心有限公司 一种磷脂酶c
EP3078741A4 (en) 2013-12-05 2017-06-21 Nagase ChemteX Corporation Flavor-improving enzyme composition, method for suppressing occurrence of unpleasant odor, and method for manufacturing food with reduced unpleasant odor
EP2910129A1 (de) 2014-02-21 2015-08-26 Clariant Produkte (Deutschland) GmbH Zusammensetzung für die enzymatische Ölentschleimung
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
CN104388448B (zh) * 2014-12-18 2018-07-03 山东大学 一种玉米磷脂酶A2基因ZmsPLA2-1及其应用
CA2980261A1 (en) 2015-04-14 2016-10-20 Dsm Ip Assets B.V. Use of phospholipase c
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN105985984B (zh) * 2015-06-17 2018-10-02 深圳益世康宁生物科技有限公司 携带pap抗原基因的重组腺相关病毒载体及构建方法与应用
BR112018000854B1 (pt) * 2015-07-17 2024-04-30 Keclon Sa Processo para degomagem de uma composição oleosa
CN106884009A (zh) * 2015-12-16 2017-06-23 丰益(上海)生物技术研发中心有限公司 高效的不依赖锌离子的磷脂酶c突变体
SG11201804731XA (en) * 2016-02-03 2018-08-30 Fuji Oil Holdings Inc Cocoa butter
BR112018015528B1 (pt) * 2016-02-03 2022-03-15 Fuji Oil Holdings Inc Método para produzir manteiga de cacau, método para obter resistência a fotodegradação, alimento semelhante a chocolate, e método para produzir o mesmo
JP2019505223A (ja) 2016-02-19 2019-02-28 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ ベーキングリパーゼ
CN106047732B (zh) * 2016-05-26 2019-09-03 江南大学 一种高分泌型耐热酵母基因工程菌及其应用
CN110129300B (zh) * 2016-06-02 2021-08-03 天津科技大学 一种磷脂酶d
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN108239667B (zh) * 2016-12-27 2022-08-12 丰益(上海)生物技术研发中心有限公司 一种磷脂酶c活力的检测方法
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
EP3401383A1 (en) 2017-05-08 2018-11-14 Bunge Oils, Inc. Process for enzymatic degumming
BR112019023695A2 (pt) 2017-05-12 2020-06-09 Basf Se formulação detergente, e, método de limpeza
EP3638763A4 (en) 2017-06-16 2021-04-28 BASF Enzymes LLC PROCESS FOR INCREASING THE OIL YIELD IN THE PRODUCTION OF ETHANOL
PL3688149T3 (pl) 2017-09-26 2025-03-24 Bunge Global Innovation, Llc. Enzymatyczne usuwanie substratów chlorofilowych z olejów na bazie triacyloglicerolu
US11542487B2 (en) 2017-10-25 2023-01-03 Basf Se Beta-amylase enzymes
CN108120761B (zh) * 2017-11-30 2020-10-16 宁波大学 基于具有电催化活性的多肽模拟物的电化学生物传感器用于乙酰胆碱酯酶检测
CN108384768A (zh) * 2018-02-28 2018-08-10 江苏中酶生物科技有限公司 一种磷脂酶c的突变体及其应用
CN108359654B (zh) * 2018-03-02 2021-11-05 江苏中酶生物科技有限公司 一种具有磷脂酶b活性的多肽或蛋白质及其应用
CN112368375A (zh) 2018-04-26 2021-02-12 巴斯夫欧洲公司 脂肪酶
EP3788145A1 (en) 2018-05-03 2021-03-10 Basf Se Amylase enzymes
ES2997165T3 (en) 2018-05-07 2025-02-14 Dsm Ip Assets Bv Process for enzymatic oil degumming
WO2020169564A1 (en) 2019-02-20 2020-08-27 Basf Se Industrial fermentation process for bacillus using defined medium and trace element feed
MX2021010110A (es) 2019-02-20 2021-09-21 Basf Se Proceso de fermentacion industrial para bacillus mediante el uso de medio definido y alimentacion de magnesio.
EP3938504A1 (en) 2019-03-11 2022-01-19 Basf Se Amylases and methods for making and using them
WO2020193534A2 (en) 2019-03-25 2020-10-01 Basf Se Amylase enzymes
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
EP3947665A2 (en) 2019-03-25 2022-02-09 Basf Se Amylase enzymes
WO2020198212A1 (en) 2019-03-27 2020-10-01 Bunge Global Innovation, Llc Silica adsorbent treatment for removal of chlorophyll derivatives from triacylglycerol-based oils
US12146171B2 (en) 2019-06-13 2024-11-19 Basf Se Method of recovering a protein from fermentation broth using a divalent cation
PL3959326T3 (pl) 2019-07-05 2023-10-09 Basf Se Przemysłowy sposób fermentacji dla komórek bakteryjnych z wykorzystaniem kultury wstępnej okresowej z zasilaniem
WO2021032881A1 (en) 2019-08-22 2021-02-25 Basf Se Amylase variants
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN112522233B (zh) * 2020-12-11 2022-05-03 中国农业大学 一种米曲霉磷脂酶c及其编码基因与应用
WO2023208768A1 (en) 2022-04-26 2023-11-02 Dsm Ip Assets B.V. Method of producing cannabis distillate
CA3257053A1 (en) 2022-05-14 2023-11-23 Novozymes A/S COMPOSITIONS AND METHODS FOR THE PREVENTION, TREATMENT, SUPPRESSION AND/OR ELIMINATION OF PHYTOPATHOGENIC INFESTATIONS AND INFECTIONS
CN116103264B (zh) * 2022-12-28 2025-05-09 厦门蓝湾科技有限公司 一种提高磷脂酶d合成ps活性的理性定向进化方法
CN120640986A (zh) 2023-02-24 2025-09-12 卡拉万成分股份有限公司 蛋类替代物组合物及其制备和使用方法
CN116574394B (zh) * 2023-04-19 2024-11-19 南京溯远基因科技有限公司 一种敏感性荧光染料剂及其制备方法
WO2024243330A1 (en) 2023-05-22 2024-11-28 Caravan Ingredients Inc. Baked goods enhancer and methods of making and using the same

Family Cites Families (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE318048B (pl) 1959-09-21 1969-12-01 Pellerin Ab Zenith
GB1541017A (en) 1975-03-10 1979-02-21 Unilever Ltd Degumming process for triglyceride oils
SE417441B (sv) 1977-08-19 1981-03-16 Kare Larsson Forfarande for att isolera polera lipider ur en blandning av polera och opolera cerealiclipider genom blandning med vatten och derpa foljande tyngdkraftsseparation
US4240972A (en) 1978-12-19 1980-12-23 Canada Packers Limited Continuous process for contacting of triglyceride oils with _an acid
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
LU83441A1 (fr) 1981-06-19 1983-04-06 Tirtiaux Sa Procede de traitement des huiles et graisses et produits ainsi obtenus
US4707364A (en) * 1984-01-27 1987-11-17 Miles Laboratories, Inc. Composition for accelerating cheese aging
US5087571A (en) 1984-06-22 1992-02-11 President And Fellows Of Harvard College Method for providing a cell culture from a transgenic non-human mammal
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3588239T3 (de) 1985-03-30 2007-03-08 Kauffman, Stuart A., Santa Fe Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
US4752483A (en) * 1986-05-30 1988-06-21 Campbell Soup Company Method for producing a highly flavored cheese ingredient
US5030240A (en) 1986-06-09 1991-07-09 The Clorox Company Enzymatic peracid bleaching system
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5573933A (en) 1987-04-14 1996-11-12 Luminis Pty, Ltd. Transgenic pigs
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5217879A (en) 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5288619A (en) * 1989-12-18 1994-02-22 Kraft General Foods, Inc. Enzymatic method for preparing transesterified oils
AU7791991A (en) 1990-04-24 1991-11-11 Stratagene Methods for phenotype creation from multiple gene populations
US5326477A (en) 1990-05-07 1994-07-05 Bio-Sep, Inc. Process for digesting solid waste
ES2217250T3 (es) 1990-06-15 2004-11-01 Scios Inc. Mamifero transgenico, no humano que muestra la patologia de formacion amiloides de la enfermedad de alzheimer.
ATE191931T1 (de) 1990-11-23 2000-05-15 Plant Genetic Systems Nv Verfahren zur transformation monokotyler pflanzen
NZ241119A (en) 1990-12-20 1993-06-25 Ixsys Inc Manipulating nucleic acid to optimize the binding characteristics of the encoded binding protein
US6110700A (en) 1991-03-11 2000-08-29 The General Hospital Corporation PRAD1 cyclin and its cDNA
DE4115938A1 (de) * 1991-05-16 1992-11-19 Metallgesellschaft Ag Enzymatisches verfahren zur verminderung des gehaltes an phosphorhaltigen bestandteilen in pflanzlichen und tierischen oelen
US5922854A (en) 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
CA2075135A1 (en) 1991-08-02 1993-02-03 David E. Ellis Particle-mediated transformation of gymnosperms
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
JPH05236997A (ja) 1992-02-28 1993-09-17 Hitachi Ltd ポリヌクレオチド捕捉用チップ
JPH06306386A (ja) 1993-04-25 1994-11-01 Showa Sangyo Co Ltd 油脂の精製方法
JP2937746B2 (ja) * 1993-04-25 1999-08-23 昭和産業株式会社 油脂の精製方法
JPH08509871A (ja) 1993-09-30 1996-10-22 アグラシータス インコーポレイテッド 異種ペルオキシダーゼを生産するトランスジェニック綿植物
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5965452A (en) 1996-07-09 1999-10-12 Nanogen, Inc. Multiplexed active biologic array
US6468742B2 (en) 1993-11-01 2002-10-22 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip
DE4339556C1 (de) 1993-11-19 1995-02-02 Metallgesellschaft Ag Verfahren zum Entschleimen von Pflanzenöl mittels Enzymen
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
NZ281041A (en) 1994-03-09 1998-04-27 Abbott Lab Non-human mammals transformed with a catalytic entity of enzymes or antibodies to produce a heterologous product in the animals milk
NZ279676A (en) 1994-03-09 1998-04-27 Abbott Lab Humanized milk produced by non-human transgenic mammal transformed with a heterologous gene coding for human enzyme producing human oligosaccharides and glycoconjugates
US5824531A (en) 1994-03-29 1998-10-20 Novid Nordisk Alkaline bacilus amylase
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5959171A (en) 1994-08-17 1999-09-28 Pharming B.V. Method for the production of biologically active polypeptides in a mammal's
EP0778886A4 (en) 1994-09-01 2001-05-02 TRANSGENIC ANIMAL WHICH EXPRESSES A FAMILY FORM OF THE HUMAN AMYLOID FOREQUARTER PROTEIN
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US5880327A (en) 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6187992B1 (en) 1994-12-05 2001-02-13 Merck & Co., Inc. Transgenic mouse having a disrupted amyloid precursor protein gene
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US6093562A (en) 1996-02-05 2000-07-25 Novo Nordisk A/S Amylase variants
US5959098A (en) 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
EP0831854A4 (en) 1995-06-06 2001-01-24 Isis Pharmaceuticals Inc OLIGONUCLEOTIDS WITH PHOSPHOROTHIOATE BINDINGS OF HIGH CHIRAL PURITY
BR9608589A (pt) 1995-06-07 1999-09-14 Willian C Orr Composições e processo de combustão em fase vapor
SK176397A3 (en) 1995-06-27 1998-07-08 Unilever Nv A method for immobilization of enzymes
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5985662A (en) 1995-07-13 1999-11-16 Isis Pharmaceuticals Inc. Antisense inhibition of hepatitis B virus replication
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
DE19527274A1 (de) * 1995-07-26 1997-01-30 Metallgesellschaft Ag Enzymatisches Verfahren zur Entschleimung von pflanzlichen Ölen mit Aspergillus-Phospholipase
SE504664C2 (sv) 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
US5721118A (en) 1995-10-31 1998-02-24 The Regents Of The University Of California, San Diego Mammalian artificial chromosomes and methods of using same
US6171820B1 (en) 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US5830696A (en) 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US6238884B1 (en) 1995-12-07 2001-05-29 Diversa Corporation End selection in directed evolution
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
US6013440A (en) 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6197070B1 (en) 1996-05-15 2001-03-06 The Procter & Gamble Company Detergent compositions comprising alpha combination of α-amylases for malodor stripping
US6057100A (en) 1996-06-07 2000-05-02 Eos Biotechnology, Inc. Oligonucleotide arrays
US6326341B1 (en) 1996-09-11 2001-12-04 The Procter & Gamble Company Low foaming automatic dishwashing compositions
JP2001504327A (ja) 1996-10-31 2001-04-03 ノボ ノルディスク アクティーゼルスカブ 新規ホスホリパーゼ、その生産及び使用
US6127137A (en) 1996-10-31 2000-10-03 Novo Nordisk A/S Acidic phospholipase, production and methods using thereof
US6103505A (en) 1996-12-09 2000-08-15 Novo Nordisk A/S Method for reducing phosphorus content of edible oils
DK0869167T4 (da) 1996-12-09 2010-03-08 Novozymes As Reduktion af phosphor-indeholdende bestanddele i spiseolier; som omfatter en stor mængde ikke-hydrerbart phosphor, ved anvendelse af en phospholipase, en phospholipase fra en trådsvamp, der har en phospholipase A og/eller B aktivitet
CZ221899A3 (cs) 1996-12-19 1999-11-17 Unilever N. V. Způsob imobilizace enzymu
US6069122A (en) 1997-06-16 2000-05-30 The Procter & Gamble Company Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution
KR100568008B1 (ko) 1997-01-17 2006-04-07 맥시겐, 인크. 반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
DE19703364A1 (de) 1997-01-30 1998-08-06 Henkel Ecolab Gmbh & Co Ohg Pastenförmiges Wasch- und Reinigungsmittel
US6303803B1 (en) 1997-01-31 2001-10-16 Cargill, Incorporated Removal of sterols from fats and oils
US5880300A (en) 1997-01-31 1999-03-09 Cargill, Incorporated Phospholipid-based removal of sterols from fats and oils
IL131966A0 (en) 1997-03-18 2001-03-19 Novo Industri As An in vitro method for construction of a dna library
JP4263248B2 (ja) 1997-03-18 2009-05-13 ノボザイムス アクティーゼルスカブ Ｄｎａのシャッフリングによるライブラリーの作成方法
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6153410A (en) 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US6826296B2 (en) 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
AU8908198A (en) 1997-08-15 1999-03-08 Hyseq, Inc. Methods and compositions for detection or quantification of nucleic acid species
DE69833698T2 (de) 1997-09-11 2006-11-16 Bioventures, Inc., Murfreesboro Verfahren zur Herstellung von Arrays hoher Dichte
US6465178B2 (en) 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
US6399383B1 (en) 1997-10-28 2002-06-04 Maxygen, Inc. Human papilloma virus vectors
EP2386568B1 (en) 1997-10-30 2014-08-06 Novozymes A/S Alpha-amylase mutants
EP1690868A1 (en) 1997-10-31 2006-08-16 Maxygen, Inc. Modification of virus tropism and host range by viral genome shuffling
DE69812403T2 (de) 1997-11-10 2004-01-29 Procter & Gamble Verfahren zur herstellung einer waschmitteltablette
CA2251263A1 (en) 1997-11-14 1999-05-14 Hajime Karasuyama Transgenic animal allergy models and methods for their use
EP1036198B1 (en) 1997-12-08 2012-09-26 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CA2320958A1 (en) 1998-02-11 1999-08-19 Maxygen, Inc. Antigen library immunization
JP2002503461A (ja) 1998-02-11 2002-02-05 マキシジェン， インコーポレイテッド 遺伝子ワクチンベクター工学
AU3463699A (en) 1998-04-03 1999-10-25 Phylos, Inc. Addressable protein arrays
AU3026399A (en) * 1998-04-08 1999-11-01 Novo Nordisk A/S An enzymatic oil-degumming process
US6156952A (en) 1998-04-09 2000-12-05 Constituent Institution Of The University Of Maryland System HIV transgenic animals and uses therefor
AU3408199A (en) 1998-05-01 1999-11-23 Novo Nordisk A/S Enhancers such as n-hydroxyacetanilide
US6048695A (en) 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
DE19824705A1 (de) 1998-06-03 1999-12-09 Henkel Kgaa Amylase und Protease enthaltende Wasch- und Reinigungsmittel
US6022567A (en) 1998-06-23 2000-02-08 Nestec S.A. Flavor enhancer
WO2000000632A1 (en) 1998-06-29 2000-01-06 Phylos, Inc. Methods for generating highly diverse libraries
JP4335995B2 (ja) 1998-07-22 2009-09-30 昭 神谷 環境保全型粒状洗浄用組成物
FR2782323B1 (fr) 1998-08-12 2002-01-11 Proteus Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues
US6183962B1 (en) 1998-09-09 2001-02-06 Millennium Pharmaceuticals, Inc. Protein kinase molecules and uses therefor
US6277628B1 (en) 1998-10-02 2001-08-21 Incyte Genomics, Inc. Linear microarrays
US6642426B1 (en) 1998-10-05 2003-11-04 David L. Johnson Fluid-bed aromatics alkylation with staged injection of alkylating agents
US6172248B1 (en) * 1998-11-20 2001-01-09 Ip Holdings, L.L.C. Methods for refining vegetable oils and byproducts thereof
US6277489B1 (en) 1998-12-04 2001-08-21 The Regents Of The University Of California Support for high performance affinity chromatography and other uses
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
WO2000055318A2 (en) 1999-03-15 2000-09-21 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
WO2000054601A1 (en) 1999-03-16 2000-09-21 Novozymes A/S Process for producing cheese
US6399121B1 (en) 1999-03-16 2002-06-04 Novozymes A/S Process for producing cheese
US6511824B1 (en) 1999-03-17 2003-01-28 Exelixis, Inc. Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
US6309871B1 (en) 1999-03-31 2001-10-30 Novozymes A/S Polypeptides having alkaline α-amylase activity
US6221653B1 (en) 1999-04-27 2001-04-24 Agilent Technologies, Inc. Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
US6653151B2 (en) 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
EP1106603A3 (en) 1999-12-06 2003-11-19 Fuji Photo Film Co., Ltd. DNA chip and reactive solid carrier
US6531644B1 (en) 2000-01-14 2003-03-11 Exelixis, Inc. Methods for identifying anti-cancer drug targets
US6515109B1 (en) 2000-10-12 2003-02-04 Exelixis, Inc. Human ECT2 polypeptide
US6309872B1 (en) 2000-11-01 2001-10-30 Novozymes Biotech, Inc Polypeptides having glucoamylase activity and nucleic acids encoding same
US6660491B2 (en) 2000-11-24 2003-12-09 Ikeda Food Research Co., Ltd. Process for producing dietary sterol fatty acid esters
JP2005517418A (ja) 2002-02-20 2005-06-16 ノボザイムス アクティーゼルスカブ チーズの製造方法
US7226771B2 (en) 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
EP1497418B1 (en) * 2002-04-19 2012-10-17 Verenium Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
CA2889013C (en) * 2003-03-07 2018-07-17 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
US20090297495A1 (en) 2005-03-08 2009-12-03 Verenium Corporation Hydrolases, nucleic acids encoding them and methods for improving paper strength
JP6449266B2 (ja) 2013-06-21 2019-01-09 バイオ−ラッド・ラボラトリーズ・インコーポレーテッド 流体ピックアップを備えるマイクロ流体システム

Also Published As

Publication number Publication date
PT1748954T (pt) 2016-11-21
JP2011172583A (ja) 2011-09-08
WO2005086900A2 (en) 2005-09-22
EP3190182A1 (en) 2017-07-12
US7226771B2 (en) 2007-06-05
ES2601431T3 (es) 2017-02-15
WO2005086900A3 (en) 2009-04-02
AU2005221136B2 (en) 2011-06-09
EP1748954A4 (en) 2009-10-28
US20050108789A1 (en) 2005-05-19
US7977080B2 (en) 2011-07-12
CN101426918B (zh) 2013-03-27
EP1748954B1 (en) 2016-08-17
BRPI0508559A (pt) 2007-08-14
CA2559060A1 (en) 2005-09-22
AU2005221136A1 (en) 2005-09-22
JP2007531516A (ja) 2007-11-08
CA2559060C (en) 2017-09-05
HUE030573T2 (en) 2017-05-29
US20080317731A1 (en) 2008-12-25
BRPI0508559B1 (pt) 2019-12-10
CN101426918A (zh) 2009-05-06
EP1748954A2 (en) 2007-02-07

Similar Documents

Publication Publication Date Title
PT1748954T (pt) Fosfolipases, ácidos nucleicos codificando-as e métodos para a sua produção e utilização
PL2057274T3 (pl) Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania
EP1497418A4 (en) PHOSPHOLIPASES, NUCLEIC ACIDS ENCODING THESE PHOSPHALIPASES AND METHODS OF MAKING AND USING
EP1727898A4 (en) AMYLASES, NUCLEIC ACIDS ENCODING THESE AMYLASES AND METHODS OF PRODUCTION AND USE OF AMYLASES
ZA200707804B (en) Cellulases,nucleic acids encoding them and methods for making and using them
PL1989302T3 (pl) Ksylanazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania
ZA200901875B (en) Phytases, nucleic acids encoding them and methods for making and using them
EP1869174A4 (en) LYASE ENZYMES, NUCLEIC ACIDS FOR THEIR CODING AND METHOD FOR THEIR PREPARATION AND USE
EP1856291A4 (en) NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME
EP2029739A4 (en) LYASE ENZYMES, NUCLEIC ACIDS FOR THEIR CODING AND METHOD FOR THEIR PREPARATION AND USE
GB0402639D0 (en) Method
GB0410478D0 (en) Method
GB0419419D0 (en) Method
GB0418651D0 (en) Method
WO2006029389A9 (en) Tryptophan-processing enzymes, nucleic acids encoding them and methods for making and using them
ZA200508046B (en) Amylases, nucleic acids encoding them and methods for making and using them
GB0412672D0 (en) Method
GB0412659D0 (en) Method
GB0414787D0 (en) Method
GB0405751D0 (en) Method
GB0419405D0 (en) Method
IL165628A0 (en) Xylanases, nucleic acids encoding them and method for making and using them
GB0415081D0 (en) Method
GB0413714D0 (en) Method
GB0417786D0 (en) Ribozymal nucleic acids B